Latest filing published 15 Oct 2026 for MapLight Therapeutics, Inc., €513k.
Insider track record
No signal scores available.
Kroeger Christopher A.: trading record in brief
Kroeger Christopher A. discloses dealings in MapLight Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 15 July 2026 to 15 October 2026, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 15 October 2026, the filings show a transaction worth €513k in MapLight Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kroeger Christopher A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 73,691 shares@ US$7.81CommonSEC144:0001974158-26-000105
- 152,230 shares@ US$37.910.96% mcap37.8% of flowCommonSEC144:0001974158-26-000080
2 of 2 declarations